When the FDA places a peptide in a restricted or high-risk category [known as Category 2], it is explicitly signaling that it has identified safety concerns and that enforcement discretion does not apply. But, as Hajduczok notes, just because something is not FDA-approved doesnt mean its illegal to compound, but the restricted peptides should not be compounded
That said, these studies are tiny
These bioactive compounds, composed of short chains of amino acids, are garnering attention in both research and clinical domains for their multifaceted roles in hair follicle biology, tissue regeneration, and cellular communication
For acute conditions such as injuries or acute illness, the effects of peptide therapy may be felt within days to weeks
Two main pathways can trigger this process, the intrinsic, also called mitochondrial pathway, when apoptosis is initiated by the internal signals of mitochondrial origin, and the extrinsic when apoptosis is activated by external stimuli [16]
And remember, carnitine fishy body odor isn't the only reason people may smell off